Azadirachtin Attenuates Carcinogen Benzo(a) Pyrene-Induced DNA Damage, Cell Cycle Arrest, Apoptosis, Inflammatory, Metabolic, and Oxidative Stress in HepG2 Cells
Antioxidants · 14.11.2023 · 12 (11) · 2001
DOI: 10.3390/antiox12112001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 14.11.2023. Verfasst von Annie John und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, College of Medicine and Health Sciences, United Arab Emirates University, 5th Postal Region, Al Ain…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Committee, College of Medicine and Health Sciences, UAE University, Al Ain, UAE, Research Committee, College of Medicine and Health Sciences, UAE University, Al Ain, U.A.E.
Abstract (Originalsprache)
Azadirachtin (AZD), a limonoid from the versatile, tropical neem tree (Azadirachta indica), is well known for its many medicinal, and pharmacological effects. Its effects as an anti-oxidant, anti-inflammatory, and anti-cancer agent are well known. However, not many studies have explored the effects of AZD on toxicities induced by benzo(a)pyrene (B(a)P), a toxic component of cigarette smoke known to cause DNA damage and cell cycle arrest, leading to different kinds of cancer. In the present study, using HepG2 cells, we investigated the protective effects of Azadirachtin (AZD) against B(a)P-induced oxidative/nitrosative and metabolic stress and mitochondrial dysfunction. Treatment with 25 µM B(a)P for 24 h demonstrated an increased production of reactive oxygen species (ROS), followed by increased lipid peroxidation and DNA damage presumably, due to the increased metabolic activation of B(a)P by CYP 450 1A1/1A2 enzymes. We also observed intrinsic and extrinsic apoptosis, alterations in glutathione-dependent redox homeostasis, cell cycle arrest, and inflammation after B(a)P treatment. Cells treated with 25 µM AZD for 24 h showed decreased oxidative stress and apoptosis, partial protection from DNA damage, and an improvement in mitochondrial functions and bioenergetics. The improvement in antioxidant status, anti-inflammatory potential, and alterations in cell cycle regulatory markers qualify AZD as a potential therapeutic in combination with anti-cancer drugs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, College of Medicine and Health Sciences, United Arab Emirates University, 5th Postal Region, Al Ain P.O. Box 15551, United Arab Emirates.
ORCID-Profile: Annie John, Haider Raza
Förderung
- Research Committee, College of Medicine and Health Sciences, UAE University, Al Ain, UAE
- Research Committee, College of Medicine and Health Sciences, UAE University, Al Ain, U.A.E
Zitieren
APA
John, A., & Raza, H. (2023). Azadirachtin Attenuates Carcinogen Benzo(a) Pyrene-Induced DNA Damage, Cell Cycle Arrest, Apoptosis, Inflammatory, Metabolic, and Oxidative Stress in HepG2 Cells. Antioxidants, 12(11), 2001. https://doi.org/10.3390/antiox12112001
Vancouver
John A, Raza H. Azadirachtin Attenuates Carcinogen Benzo(a) Pyrene-Induced DNA Damage, Cell Cycle Arrest, Apoptosis, Inflammatory, Metabolic, and Oxidative Stress in HepG2 Cells. Antioxidants. 2023;12(11):2001. doi:10.3390/antiox12112001
BibTeX
@article{John2023,
author = {John, Annie and Raza, Haider},
title = {Azadirachtin Attenuates Carcinogen Benzo(a) Pyrene-Induced DNA Damage, Cell Cycle Arrest, Apoptosis, Inflammatory, Metabolic, and Oxidative Stress in HepG2 Cells},
journal = {Antioxidants},
year = {2023},
volume = {12},
number = {11},
pages = {2001},
doi = {10.3390/antiox12112001}
}
EUVIMED